News

26 May 2026

Ineos Expands Recycled Polypropylene Portfolio For Cosmetics Packaging

The Europe polypropylene market size is valued at USD 29.99 billion in 2026 and is expected to hit USD 42.50 billion by 2035, exhibiting at a CAGR of 3.95%.

26 May 2026

Nippon Paint India Expands Automotive Care Business With FX10 Launch

Asia Pacific paints & coatings market size to reach USD 111.05 billion in 2026 and is expected to surpass around USD 182.11 billion by 2035 with a CAGR of 5.65%

26 May 2026

Quantum Computing Advances Material Informatics Research In Asia Pacific

The Asia Pacific material informatics market size was valued at USD 412.95 million in 2025, is estimated to reach USD 486.66 million in 2026, and is projected to reach USD 2,133.99 million by 2035, exhibiting a compound annual growth rate (CAGR) of 17.85% over the forecast period from 2026 to 2035.

26 May 2026

Clean Harbors Strengthens Hazardous Wastewater Treatment Industry Business

The global hazardous wastewater treatment market size is valued at USD 23.46 billion in 2026 and is expected to hit USD 40.14 billion by 2035, exhibiting at a CAGR of 6.15%.

26 May 2026

New and Advanced Biomarker Could Guide Future Brain-Targeted Therapies for Pompe Disease

Researchers identify an advanced biomarker that could improve brain-targeted therapies and treatment monitoring for Pompe disease patients.

26 May 2026

Geotab Accelerates Indonesia’s Fleet Safety Evolution With AI-Powered GO Focus Plus Dash Cam

Geotab launches GO Focus Plus in Indonesia, enabling AI-powered fleet safety, driver monitoring, and real-time video telematics.

26 May 2026

Lirum Therapeutics Announces Positive LX-101 Data for Presentation at AACR 2026

Lirum Therapeutics announced positive LX-101 data in Ewing sarcoma selected for presentation at the AACR 2026 Annual Meeting, highlighting advances in targeted oncology therapies and PDX model research.

26 May 2026

Medtronic Expands Neuromodulation Reach with Adaptive DBS Launch in India

Medtronic has launched its Adaptive Deep Brain Stimulation (aDBS) system in India to provide real-time personalized therapy for Parkinson’s disease, strengthening innovation in the neuromodulation market.

26 May 2026

Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program 

Waiv has partnered with Daiichi Sankyo to develop AI-derived biomarkers for antibody-drug conjugate programs using digital pathology, immunohistochemistry, and computational AI technologies.

25 May 2026

DHL Express Expands Global Freight Capabilities with Launch of Heavy Weight Express Service

DHL Express expands global freight logistics with its new Heavy Weight Express Service, enabling faster and efficient large cargo shipping worldwide.

25 May 2026

Microban Presenting and Exhibiting at the American Coatings Show 2026 

Microban will showcase advanced antiviral and antimicrobial coating technologies at the American Coatings Show 2026, highlighting innovations for healthcare, industrial, and textile applications.

25 May 2026

ChristianaCare Launches DECODR, Inc. to Bring Advanced, Accurate Gene Editing Analysis to Scientists Worldwide

ChristianaCare has launched DECODR, Inc., a new company focused on delivering advanced CRISPR gene editing analysis software to researchers worldwide. The platform helps scientists accurately evaluate DNA edits in seconds.

25 May 2026

Ingersoll Rand Acquires Fox s.r.l., Expanding Metering and Dosing Capabilities

Ingersoll Rand has acquired Fox s.r.l. to expand its metering and dosing technology portfolio. The acquisition strengthens flow control solutions for pharmaceutical, life science, and industrial pumping applications.

22 May 2026

Roche Receives CE Mark for Elecsys® pTau217 Blood Test for Alzheimer’s Diagnosis

Roche receives CE Mark approval for the Elecsys pTau217 blood test to support earlier and more accurate Alzheimer’s diagnosis.

22 May 2026

Epson Launches its New Business Printer Range with Higher Speed and For Higher Print Volume Environment

Epson unveils a new business printer range designed for high-speed printing and high-volume office environments with enhanced efficiency.

22 May 2026

Piramal Pharma Solutions Expands U.S. ADC Manufacturing with New Michigan Payload-Linker Suite 

Piramal Pharma Solutions has expanded its U.S. pharmaceutical manufacturing operations with a new Michigan payload-linker suite to support ADC therapies and advanced bioconjugate drug development.

22 May 2026

New 3D Bioprinting Technique Advances Personalized Regenerative Medicine 

Scientists at Trinity College Dublin developed a new 3D bioprinting technique that improves tissue engineering and regenerative medicine by enabling better control of cartilage, tendon, and ligament formation.

22 May 2026

At-Home DNA Testing Expands Beyond Paternity

Demand for at-home DNA testing is increasing beyond paternity cases as more families use sibling, grandparent, and kinship tests to confirm biological relationships quickly and privately.

21 May 2026

Spear Bio Launches Ultrasensitive Assays to Advance Parkinson’s Disease Biomarker Testing

Spear Bio launches ultrasensitive immunoassays for Parkinson’s and Alzheimer’s biomarker testing to support earlier disease detection.

21 May 2026

Junglee Games Reinvents Its India Strategy With Launch of Social Learning Platform “Zuvo”

Junglee Games expands in India with Zuvo, a new social learning platform focused on interactive education and digital engagement.

21 May 2026

Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 2026 

Revolune GmbH and MindPeak will exhibit at AACR 2026, highlighting AI-driven pathology and multiplex immunofluorescence tools that improve spatial biology research and cancer diagnostics.

21 May 2026

Thermo Fisher Launches Gibco™ CTS™ DynaXS™ Single Use Bioreactor to Advance Scalable Cell Therapy Manufacturing

Thermo Fisher Scientific launches the Gibco CTS DynaXS Single-Use Bioreactor to support scalable, flexible, and compliant cell therapy manufacturing for growing demand in personalized medicine and oncology treatments.

21 May 2026

Zoetis Announces First AI Analyser Update

Zoetis has expanded its Vetscan OptiCell with AI-powered features, including CHCM and PCT, enabling faster and more accurate animal blood test results at the point of care for better veterinary decision-making.

20 May 2026

Savita Oil Technologies Expands Synthetic Ester Capacity for Offshore Lubricants

Savita Oil Technologies has expanded synthetic ester manufacturing capacity at its Mahad facility to support growing demand in the offshore lubricants market. The expansion strengthens supply for offshore drilling, marine equipment, EV cooling fluids, immersion cooling, and high-performance industrial lubricant applications.

20 May 2026

Advancing Alzheimer's Care: Voyager's Tau-Silencing Gene Therapy Breakthrough

Voyager unveils a breakthrough tau-silencing gene therapy aimed at slowing Alzheimer’s progression with next-generation neurodegenerative care.

20 May 2026

Dr. Reddy’s and Nestlé Health Science launch Celevida GLP+ for people undergoing GLP-1/GIP therapy in India.

Dr. Reddy’s and Nestlé Health Science launched Celevida GLP+ in India to support nutrition and muscle health for patients receiving GLP-1/GIP therapy for obesity and type 2 diabetes.

20 May 2026

Haut.AI to introduce a new standard in skin measurement at New York Suppliers’ Day 2026

Haut.AI introduced its Face180° AI-powered skin measurement platform at New York Suppliers’ Day 2026, advancing personalized skincare, digital beauty, and AI-driven skin diagnostics.

20 May 2026

Dr. Reddy’s and Nestlé Health Science Launch Nutrition Product for Patients on Obesity Drugs.

Dr. Reddy’s and Nestlé Health Science introduced Celevida GLP+ to support nutrition and muscle health in patients using GLP-1 therapies for obesity and diabetes. Rising demand for personalized medical nutrition therapy is driving market growth.

19 May 2026

Protein Degraders Gain Speed as Arvinas Scores Landmark Approval.

Arvinas received landmark FDA approval for its PROTAC protein degrader therapy, marking a breakthrough in targeted protein degradation and precision medicine. Growing innovations in PROTACs and molecular glues are driving market growth.

19 May 2026

Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio

Stealth BioTherapeutics reported strong early demand for FORZINITY, the first FDA-approved therapy for Barth syndrome. Growing innovation in mitochondrial medicine and biotherapeutics is driving market growth worldwide.